High-Growth, Innovative Nutraceutical Opportunity
Gross Revenue: | $11,028,987 |
EBITDA: | $3,178,100 |
Inventory: | $1,169,650 |
Established Year: | 2010 |
Established Pharmaceutical Company: Portfolio of 12 well-branded, highly-recognizable products for children,
adults, and pets. Strong Financial Performance: Estimated to capture ~$10 million in annual revenue with an impressive 21% CAGR since 2020. Logistical Efficiency: Identified strategic logistical improvements poised to double net income.